The Plozalizumab Biosimilar Anti-CCR2 Antibody offered by Assay Genie is a cutting-edge tool for research involving C-C chemokine receptor type 2 (CCR2), a key player in inflammation and immune responses. This biosimilar antibody, produced through advanced biotechnology processes, demonstrates high specificity and sensitivity in binding to CCR2 in human samples, enabling precise detection and analysis in various experimental settings.CCR2 is a chemokine receptor involved in recruiting inflammatory cells to sites of injury or infection, making it a crucial target for understanding and potentially modulating immune responses in conditions such as cancer, autoimmune disorders, and inflammatory diseases.
The Plozalizumab Biosimilar Anti-CCR2 Antibody provides researchers with a reliable tool to investigate the role of CCR2 in these diseases, offering new insights into potential therapeutic strategies.With its exceptional performance in assays like Western blotting, this biosimilar antibody facilitates accurate and reproducible data in immunology and cancer research studies. Its versatility and reliability make it a valuable asset for scientists aiming to unravel the complexities of CCR2-mediated pathways and explore new avenues for therapeutic intervention. Trust in the Plozalizumab Biosimilar Anti-CCR2 Antibody from Assay Genie for your cutting-edge research needs.
Product Name:
Plozalizumab (Anti-CCR2) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0080
Target:
CCR2
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
MLN-1202, MLN1202, anti-CCR2, hu1D9
Description:
Anti-CCR2(plozalizumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
